2011
DOI: 10.1016/j.soncn.2011.02.003
|View full text |Cite
|
Sign up to set email alerts
|

The Challenges of Oral Agents as Antineoplastic Treatments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
65
0
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 86 publications
(67 citation statements)
references
References 93 publications
0
65
0
2
Order By: Relevance
“…Recent progress in treatment of cancer has accelerated an expansion of the development of oral anticancer agents [1]. The availability of oral anticancer agents has a major impact on cancer care.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Recent progress in treatment of cancer has accelerated an expansion of the development of oral anticancer agents [1]. The availability of oral anticancer agents has a major impact on cancer care.…”
Section: Introductionmentioning
confidence: 99%
“…Optimal adherence is achieved “if no doses are missed, no extra doses are taken, and no doses are taken in the wrong quantity or at the wrong time” [10]. In general, a patient is considered to be adherent if he or she has taken 80% of a prescribed medication [1]. …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…19 Given and colleagues elucidated almost the same issues, adding outcome expectations, health literacy, disease type and stage, and out-of-pocket costs. 28 Moore and Winklejohn discussed factors such as patient history, motivation and relationship with the healthcare provider as important in promoting adherence. When stressing the importance of individualised patient education, these authors recommended the MOATT as a resource.…”
Section: Discussionmentioning
confidence: 99%
“…With the increasing use of oral agents in cancer treatment (Given, Spoelstra, & Grant, 2011), responsibility for the delivery of treatment has shifted to patients who must rely on themselves and their support systems to accomplish basic aspects of cancer care (e.g., some adverse events management, treatment adherence, drug storage, drug handling, drug administration) between clinic visits. The role of self-care in the management of cancer is pronounced with CML because the standard of care is continuous dosing of TKI therapy for an indefinite period of time.…”
Section: Empowerment and The Patient Role In Managing Chronic Myeloidmentioning
confidence: 99%